This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kura Oncology, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Jing Tao - Innovator in Pharmaceutical Compositions
Introduction
Jing Tao is a notable inventor based in San Diego, CA, who has made significant contributions to the field of pharmaceuticals. His innovative work focuses on developing compositions that include MENIN inhibitors, which have potential therapeutic applications.
Latest Patents
Jing Tao holds a patent for "Pharmaceutical compositions comprising a MENIN inhibitor." This patent describes crystalline forms of a specific compound, including methods for making these forms and the pharmaceutical compositions that incorporate them. The compound is detailed as (S)-4-methyl-5-((4-((2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)methyl)-1-(2-(4-(methylsulfonyl)piperazin-1-yl)propyl)-1H-indole-2-carbonitrile or its solvates. Jing Tao has 1 patent to his name.
Career Highlights
Jing Tao is currently associated with Kura Oncology, Inc., where he continues to advance his research and development efforts in the pharmaceutical sector. His work is pivotal in exploring new therapeutic avenues for various diseases.
Collaborations
Throughout his career, Jing has collaborated with esteemed colleagues, including Dipanjan Sengupta and Patricia Andres, who contribute to the innovative environment at Kura Oncology.
Conclusion
Jing Tao's contributions to pharmaceutical compositions highlight his role as a key inventor in the industry. His work on MENIN inhibitors showcases the potential for new treatments and underscores the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile